Commissioner Orders Benchmark Workers’ Comp Rate Reduction
InterWest Insurance Services
AUGUST 6, 2024
Another analysis performed in early 2023 projects total savings from biosimilars to range from $125 billion to $237 billion between 2023 and 2027. One report estimates that the savings generated by biosimilars in 2022 was $9.4 billion in the United States.
Let's personalize your content